期刊文献+

肿瘤干细胞免疫逃逸机制的研究进展 被引量:4

Advances of the research on mechanisms of tumor stem cells-immune escape
原文传递
导出
摘要 肿瘤干细胞是肿瘤发生、发展、转移及复发的根源。虽然机体有严密的免疫监视机制,但肿瘤干细胞可以通过改变表面抗原、表达免疫逃逸相关基因及逃逸相关的表面标志物,或诱导具有免疫抑制能力的细胞或细胞因子的分泌等多种机制有效地逃避免疫系统的监视。此外,肿瘤干细胞免疫逃逸与其微环境中的各种间质细胞和细胞外因子的作用也密切相关。这些机制的研究有助于加深对肿瘤干细胞的认识,为肿瘤的预防和治疗提供新的理论指导。 Tumor stem cells are the root of tumor development, metastasis and recurrence. Although the body has various immunosurveillance mechanisms, tumor stem cells can evade immunosurveillance effectively via changing the surface antigens, expressing immune escape associated genes and surface markers, or inducing immune suppressive cells and eytokines secretion. In addition, the role of various mesenchymal ceils and cytokines in tumor microenviroument are also closely related to tumor stem cells immune escape. Studies of these mechanisms will contributed to a better understanding of tumor stem cells. It provided a new theoretical instruction for tumor prevention and treatment. Our review focused on the advancements of the mechanisms of tumor stem cells escaping the attacking of immune system.
出处 《国际免疫学杂志》 CAS 北大核心 2011年第4期270-273,共4页 International Journal of Immunology
基金 天津市自然科学基金资助项目(11JCYBJC13200)
关键词 肿瘤干细胞 免疫逃逸 Tumor stem cells Immune escape
  • 相关文献

参考文献27

  • 1Reya T, Morrison SJ, Clarke MF, et al. Stem cell, cancer, and cancer stem cells. Nature, 2001, 414(6859) : 105-111.
  • 2Deng W, Han Q, Liao L, et al. Allogeneic bone marrow-derived flk-I + Sea-l- mesenchymal stem cells leads to stable mixed chim- erism and donor-specific tolerance. Exp Hematol , 2004, 32 (9) : 861-867.
  • 3Wu A, Wiesner S, Xiao J, et al . Expression of MHC-I and NK ligands on human CD133 + glioma cells : possible targets of im- munotherapy. J Neurooncol, 2007, 83 (2) : 121-131. and chemoresistance of CD133 + cancer stem ceils inglioblasoma. Mol Cancer, 2006, 5: 67. Taieb N , Maresca M, Guo XJ , et al. The first extracellular do-.
  • 4Li Z, Bao S, Wu Q, et al. Hypoxia- Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells. Cancer Cell, 2009, 15(6) : 501- 513.
  • 5Trapani JA, Sutton VR. Granzyme B: pro- apoptotic, antiviral and antitumor functions. Curt Opin Immunol, 2003, 15 (5) : 533- 543.
  • 6Kawasaki BT, Mistree T, Hurt EM,et al. Co-expression of the tol- eragenic glycoprotein, CD200, with markers for cancer stem cells. Bioebem Biophys Res Commun, 2007, 364(4) : 778-782.
  • 7Kretz-Rommel A, Qin F," Dakappagari N, et al. CD200 expres- sion on tumor cells suppresses antitumor immunity: new approa- ches to cancer immunotherapy. J lmmunol, 2007,178(9) : 5595- 5605.
  • 8Ji J, Black KL, Yu JS. Glioma stem cell research for the develop- ment of immunotherapy. Neurosurg Clin N Am, 2010 , 21 (1) : 159-166 .
  • 9Yao J, Zhang T, Ren J, et al. Effect of CD133/prominin-1 anti- sense oligodeoxynucleotide on in vitro growth characteristics of Huh-'/ human hepatocarcinoma ceils and U251 human glioma cells. Oneol Rep, 2009, 22(4) :781-787.
  • 10Liu G, Yuan X, Zeng Z, et al , Analysis of gene expression and chemoresistanee of CD133 + cancer stem ceils inglioblasoma. Mol Cancer, 2006, 5: 67.

同被引文献91

  • 1齐卫卫,胡国清.Survivin蛋白在鼻咽癌组织中的表达及临床意义[J].中华耳鼻咽喉科杂志,2004,39(12):759-760. 被引量:2
  • 2邹继彬,黄广恩,陈中坚,陈鸿莲.Survivin蛋白和PCNA在鼻咽癌中的表达及其临床意义[J].中国医师杂志,2004,6(12):1636-1638. 被引量:5
  • 3姜武忠,卢景琛,文继舫,廖遇平,张静,朱红,冯德云,沈明.鼻咽癌组织中nm23-H_1和survivin蛋白表达及其临床意义[J].中华放射肿瘤学杂志,2005,14(5):383-387. 被引量:7
  • 4韩广荣,何丽霞.以复视首诊眼科的鼻咽癌五例分析[J].中国实用眼科杂志,2007,25(5):491-491. 被引量:1
  • 5Freeman GJ, Casasnovas JM, Umetsu DT,et al. TIM genes : afamily of cell surface phosphatidylserine receptors that regulate in-nate and adaptive immunity. Immunol Rev, 2010,235 ( 1 ) : 172-189.
  • 6Zhu C,Anderson.AC, Kuchroo VK. TIM-3 and its regulatory rolein immune responses. Curr Top Microbiol Immunol,.2011,350 : 1 -15.
  • 7Norling LV,Perretti M,Cooper D. Endogenous galectins and thecontrol of the host inflammatory response. J Endocrinol, 2009,201(2) ;169-184.
  • 8Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, et al. The cos-timulatory role of TIM molecules. Immunol Kev, 2009, 229( 1 ):259-270.
  • 9Cao E, Zang X, Ramagopal UA, et al. T cell immunoglobulinmucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity, 2007 , 26(3) : 311-321.
  • 10van de Weyer PS, Muehlfeit M, Klose C, et al. A highly con-served tyrosine of Tim-3 is phosphorylated upon stimulation by itsligand galectin-9. Biochem Biophys Res Commun, 2006, 351(2) : 571-576.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部